Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSMB5 | P28074 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | PLA2G10 | O15496 | 2/20 | 0.31 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18882586 | 0.85 | LMNA (0.30) | LMNA | |
| SCHEMBL12570564 | 0.79 | RNPEP (0.39) | PSMB5ALDH1A1 | |
| SCHEMBL18880055 | 0.76 | CPB2 (0.34) | — | |
| SCHEMBL13995992 | 0.76 | TDP1 (0.44) | MEN1ALDH1A1LMNAKMT2A | |
| SCHEMBL20445378 | 0.74 | ALDH1A1 (0.42) | PSMB5MEN1ALDH1A1LMNAKMT2A | |
| SCHEMBL24421009 | 0.74 | ALDH1A1 (0.42) | PSMB5MEN1ALDH1A1LMNAKMT2A | |
| SCHEMBL24420991 | 0.74 | ALDH1A1 (0.42) | PSMB5MEN1ALDH1A1LMNAKMT2A | |
| SCHEMBL11128512 | 0.73 | TDP1 (0.37) | ALDH1A1 | |
| SCHEMBL15592753 | 0.69 | CACNA2D1 (0.45) | MEN1ALDH1A1LMNAKMT2APLA2G10 | |
| SCHEMBL13851589 | 0.69 | CACNA2D1 (0.45) | MEN1ALDH1A1LMNAKMT2APLA2G10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220143038-A1 | LIPID PRODRUGS OF MYCOPHENOLIC ACID AND USES THEREOF | PURETECH LYT, INC. (US) | 2022-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220143038-A1 | LIPID PRODRUGS OF MYCOPHENOLIC ACID AND USES THEREOF | MALT1, CYP2B6, LIPA | PSMB5 2452/4885MEN1 1358/4885ALDH1A1 959/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.